(Q42616372)

3 November 2017

title

Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy (English)

1 reference

subacute cutaneous lupus erythematosus

3 November 2017

main subject

0 references

author name string

Kreuter A

1

1 reference

3 November 2017

Tomi NS

2

1 reference

3 November 2017

Weiner SM

3

1 reference

3 November 2017

Huger M

4

1 reference

3 November 2017

Altmeyer P

5

1 reference

3 November 2017

Gambichler T

6

1 reference

3 November 2017

language of work or name

English

0 references

publication date

4 April 2007

1 reference

British Journal of Dermatology

3 November 2017

published in

1 reference

3 November 2017

volume

156

1 reference

3 November 2017

issue

6

1 reference

3 November 2017

page(s)

1321-1327

1 reference

Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Treatment of subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Update on the management of cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

The cutaneous pathology of lupus erythematosus: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Management of skin disease in patients with lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Anti-malarials in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Pimecrolimus 1% cream for cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Lymphocytopenia in lupus erythematosus: close in vivo association to autoantibodies targeting nuclear antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

Association between Discoid Lupus erythematosus and Cigarette Smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07826.X

10.1111/J.1365-2133.2007.07826.X

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference